Skip to main content

Manuel Requena Ruiz

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Manuel Requena Ruiz

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Projects

Influencia de factores clínicos, marcadores de neuroimagen y parámetros de laboratorio en el control de la presión arterial tras una hemorragia intracerebral aguda

IP: David Rodriguez Luna
Collaborators: Influencia de factores clínicos, marcadores de neuroimagen y parámetros de laboratorio en el control de la presión arterial tras, Noelia Rodríguez Villatoro, Manuel Requena Ruiz, Olalla Pancorbo Rosal
Funding agency: Instituto de Salud Carlos III
Funding: 40000
Reference: PI23/01061
Duration: 01/01/2024 - 31/12/2026

Direct to Angiography Suite Without Stopping for Computed Tomography Imaging for Patients With Acute Stroke A Randomized Clinical Trial

IP: Manuel Requena Ruiz
Collaborators: -
Funding agency: Fundación Mutual Médica
Funding: 3000
Reference: MUTUALMEDICA/PREMI/REQUENA
Duration: 25/11/2022 - 25/11/2022

HARMONICS. Harmonization and Implementation of High Value Stroke Care

IP: Carlos Molina Cateriano
Collaborators: Maria Baladas Orti, Ester Sanchez Gavilan, Cristina Guirao Martinez, Estefania Montiel, Marina Jimenez Iglesias, Lidia Garcia Guillamón, Judith Cendrero Correa, Federica Rizzo, Marta Aurora Rubiera Del Fueyo, David Rodriguez Luna, Manuel Requena Ruiz, Marta Olive Gadea, Alvaro Garcia Tornel Garcia Camba, Marc Rodrigo Gisbert
Funding agency: EUROPEAN COMMISSION
Funding: 468090
Reference: HARMONICS_EIT-HEALTH-BP2022
Duration: 01/01/2022 - 31/12/2024

Evaluación ultra-rápida en la sala de angiografía vs. tomografía convencional en la indicación del tratamiento endovascular del ictus agudo.

IP: Marc Ribó Jacobi
Collaborators: Manuel Requena Ruiz
Funding agency: Fundació Institut de Recerca HUVH
Funding: 42000
Reference: HUVH/BPFSE_RENOV/2020
Duration: 01/06/2020 - 31/05/2022

Related news

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

The award is a recognition for his significant contribution to the development of research in multiple sclerosis within the Catalan Institute of Health.

Related professionals

Sara Isabel Reidel

Sara Isabel Reidel

Research technician
Childhood Cancer and Blood Disorders
Read more
Montse Martinez Muñoz

Montse Martinez Muñoz

Multidisciplinary Nursing Research Group
Read more
Débora Ferrate Navarro

Débora Ferrate Navarro

Administrative
National Unit
Competitive Research Directorate
Read more
Gloria Palomar Martínez

Gloria Palomar Martínez

Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.